Aztreonam Completed Phase 2 Trials for Cystic Fibrosis (CF) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02730793Aztreonam Aerosol to Treat Cystic Fibrosis Nasal Disease
NCT01375049Aztreonam Lysine for Pseudomonas Infection Eradication Study